Search

everythinglearnresearchcommunity

for

Search:↓

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Scientists now better understand how human hair growth is controlled, including the roles of specific genes and proteins.

Women with PCOS are much more likely to experience depression.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Women with PCOS often have acne, obesity, and excess hair, especially on the chin and upper lip.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Women with PCOS are more likely to have skin problems like excessive hair, acne, and hair loss.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

Skin changes in women with PCOS are mainly due to hormonal imbalances.